Polyrizon Ltd. Price & Performance (PLRZ)

Array Technologies is set to take part in the 37th Annual ROTH Conference on March 17, 2025. Leadership, including President Neil Manning and CFO Keith Jennings, will engage in one-on-one meetings. Key company insights will be shared through a presentation available on their investor relations page.1

Polyrizon Ltd. will hold its Annual General Meeting on April 17, 2025, in Israel. Shareholders can vote via proxy, with materials provided in SEC filings. The company has seen a 37% stock increase over six months and is expected to report fiscal year profitability in its upcoming earnings.2

Polyrizon has initiated preclinical studies for intranasal Naloxone, targeting the $2.47 billion opioid treatment market. Using its proprietary Trap and Target platform, the company aims to enhance drug delivery efficiency. This marks an early step in a lengthy development process, aiming to address a critical healthcare need.3